| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/05/2014 | CA2840937A1 Vaccine composition for transdermal administration |
| 08/05/2014 | CA2689476C Intranasal carbetocin formulations and methods for the treatment of autism |
| 08/05/2014 | CA2680606C Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery |
| 08/05/2014 | CA2673193C Homogeneous paste and gel formulations |
| 08/05/2014 | CA2654264C Inhalant powder containing phenylalanine |
| 08/05/2014 | CA2643037C Compositions and methods for delivery of amino-functional drugs |
| 08/05/2014 | CA2611133C Rapidly-dissolving pharmaceutical composition for inhibiting ovulation |
| 08/05/2014 | CA2549333C Treatment of ophthalmic conditions |
| 08/05/2014 | CA2549038C Aqueous suspensions of ciclesonide for nebulisation |
| 08/05/2014 | CA2527712C Ophthalmic compositions containing a synergistic combination of two polymers |
| 08/05/2014 | CA2522868C Vector comprising gastric protection for oral administration |
| 07/31/2014 | WO2014117035A1 COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS |
| 07/31/2014 | WO2014117010A2 Composition for ophthalmic administration |
| 07/31/2014 | WO2014116866A1 Method for diagnosing or treating tumors using sphingomyelin containing liposomes |
| 07/31/2014 | WO2014116787A1 Poly(nitrogen/amine) derivatives of a natural wax and ophthalmic compositions |
| 07/31/2014 | WO2014116770A1 Production of unit dose constructs |
| 07/31/2014 | WO2014116723A1 Multivalent liposome formulations |
| 07/31/2014 | WO2014116043A1 Biodegradable microbeads comprising dextran methacrylate and biocompatible anionic polymer, and preparation method therefor |
| 07/31/2014 | WO2014115488A1 Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida |
| 07/31/2014 | WO2014115487A1 Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus |
| 07/31/2014 | WO2014115127A1 Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide |
| 07/31/2014 | WO2014115082A1 Pharmaceutical formulations of imatinib |
| 07/31/2014 | WO2014114956A1 Freeze-dried composition |
| 07/31/2014 | WO2014114946A1 Formation of particle structures |
| 07/31/2014 | WO2014114786A1 Pharmaceutical combinations of flurbiprofen, glucosamin and capsaicin |
| 07/31/2014 | WO2014114575A1 Pharmaceutical composition with improved bioavailability |
| 07/31/2014 | WO2014106116A3 Therapeutic compositions comprising antibodies |
| 07/31/2014 | WO2014104784A4 Sustained-release lipid pre-concentrate of cationic pharmacologically active substance and pharmaceutical composition comprising the same |
| 07/31/2014 | WO2014071212A3 Stable dual variable domain immunoglobulin protein formulations |
| 07/31/2014 | WO2014063985A3 Encapsulated bitter peptides, methods of encapsulating bitter peptides, and nutritional compositions including encapsulated bitter peptides |
| 07/31/2014 | WO2014043346A3 Anti-pain and anti-nausea and/or vomiting combinatorial compositions |
| 07/31/2014 | US20140213984 Octreotide injection |
| 07/31/2014 | US20140213666 Reaction product of a polar modified polymer and an alkoxysilane and a composition containing the reaction product |
| 07/31/2014 | US20140213659 Modified release formulations of memantine oral dosage forms |
| 07/31/2014 | US20140213655 Method of treating stroke comprising administering metal chelators to the upper one-third of the nasal cavity |
| 07/31/2014 | US20140213653 Directly compressible proprionic acid derivative particles |
| 07/31/2014 | US20140213644 Formulations and Methods for Prevention and Treatment of Oral Allergy Syndrome |
| 07/31/2014 | US20140213641 Polymeric nanoparticles for drug delivery |
| 07/31/2014 | US20140213625 Methods and Compositions for Treating Foot or Hand Pain |
| 07/31/2014 | US20140213622 Pharmaceutical compositions comprising an aromatse inhibitors |
| 07/31/2014 | US20140213606 Pharmaceutical Formulation Containing Gelling Agent |
| 07/31/2014 | US20140213565 Soluble estradiol capsule for vaginal insertion |
| 07/31/2014 | US20140213538 Lysophosphatidic acid receptor antagonists |
| 07/31/2014 | US20140213532 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/31/2014 | US20140213503 Solid composition |
| 07/31/2014 | US20140212572 Pharmaceutical compositions for the coordinated delivery of nsaids |
| 07/31/2014 | US20140212505 Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals |
| 07/31/2014 | US20140212504 Phospholipid-based powders for drug delivery |
| 07/31/2014 | US20140212503 Delivery system |
| 07/31/2014 | US20140212502 Nano- and micro-bubbles with ultrasound-triggered release and imaging functionalities |
| 07/31/2014 | US20140212501 Compositions of lopinavir |
| 07/31/2014 | US20140212500 Compositions containing diverse natural antigens and uses thereof in balancing immune responses |
| 07/31/2014 | US20140212499 Compositions and methods for repairing bone |
| 07/31/2014 | US20140212498 Oil-in-water emulsions that contain nucleic acids |
| 07/31/2014 | US20140212496 New abuse-resistant pharmaceutical composition for the treatment of opioid dependence |
| 07/31/2014 | US20140212495 Nanoparticulate compositions of tubulin inhibitor compounds |
| 07/31/2014 | US20140212494 Methods of Improving Digestive Health |
| 07/31/2014 | US20140212493 Highly Bioavailable Composition Containing Eprosartan - Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex |
| 07/31/2014 | US20140212492 Oral Enzyme Compositions for Intestinal Delivery |
| 07/31/2014 | US20140212491 Combination formulation of two antiviral compounds |
| 07/31/2014 | US20140212490 Tablet for pulsed delivery |
| 07/31/2014 | US20140212489 Pharmaceutical compositions for the coordinated delivery of nsaids |
| 07/31/2014 | US20140212488 Oral tablet formulation consisting of immediate release rosuvastatin and extended release metformin |
| 07/31/2014 | US20140212485 Inhibitors of bruton's tyrosine kinase |
| 07/31/2014 | US20140212484 Multilayered polyelectrolyte-based capsules for cell encapsulation and delivery of therapeutic compositions |
| 07/31/2014 | US20140212483 Compositions for Treatment of Attention Deficit Hyperactivity Disorder |
| 07/31/2014 | US20140212482 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same |
| 07/31/2014 | US20140212480 Ceramide anionic liposome compositions |
| 07/31/2014 | US20140212479 Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers |
| 07/31/2014 | US20140212477 Hemoglobin-containing liposome and method for producing same |
| 07/31/2014 | US20140212476 Method of Targeting Hydrophobic Drugs to Vascular Lesions |
| 07/31/2014 | US20140212474 Drug carriers |
| 07/31/2014 | US20140212473 Glycopeptide and uses thereof |
| 07/31/2014 | US20140212469 Surface functional bioactive glass scaffold for bone regeneration |
| 07/31/2014 | US20140212466 Method of preparing carrier liquids |
| 07/31/2014 | US20140212463 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
| 07/31/2014 | US20140212462 POLYMER NANOPARTICLE INJECTION FORMULATION COMPOSITION CONTAINING RAPAMYCIN WITH IMPROVED WATER SOLUBILITY, PREPARATION METHOD THEREOF, AND ANTICANCER COMPOSITION FOR COMBINED USE WITH RADIOTHERAPY (as amended) |
| 07/31/2014 | US20140212461 Methods for Treatment of Attention Deficit Hyperactivity Disorder |
| 07/31/2014 | US20140212421 Methods and compositions for enhanced delivery of macromolecules |
| 07/31/2014 | US20140212404 Compositions and Methods for Treating Injuries to the Visual System of a Human |
| 07/31/2014 | US20140212391 Vaginal laxity therapy utilizing cell-based bulking compositions |
| 07/31/2014 | US20140212355 Trans-arterial drug delivery |
| 07/31/2014 | US20140210117 Pharmaceutical compositions of dispersions of drug and neutral polymers |
| 07/31/2014 | US20140209100 Intravaginal devices for drug delivery |
| 07/30/2014 | EP2759513A1 Method for preparing nano particles |
| 07/30/2014 | EP2759294A1 Percutaneously absorbable preparation containing fentanyl and a homologue thereof |
| 07/30/2014 | EP2759293A1 Pharmaceutical compositions of (+)-(s)-2-(3-benzoylphenyl)propionic acid tromethamine salt |
| 07/30/2014 | EP2759292A1 Dual action, inhaled formulations providing both an immediate and sustained release profile |
| 07/30/2014 | EP2759291A1 Therapeutic microfoams |
| 07/30/2014 | EP2759290A1 Sprayable liquid composition especially for nasal application having an increased local retention time |
| 07/30/2014 | EP2758114A2 Inhalable microemulsion comprising anaesthetic |
| 07/30/2014 | EP2758065A2 Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations |
| 07/30/2014 | EP2758040A1 Nicotine-containing pharmaceutical composition |
| 07/30/2014 | EP2758039A1 Biosensor with error compensation |
| 07/30/2014 | EP2758038A2 Novel influenza hemagglutinin protein-based vaccines |
| 07/30/2014 | EP2758037A1 Self-assembled nano-structure particle and method for preparing |
| 07/30/2014 | EP2758036A2 Nano delivery systems |
| 07/30/2014 | EP2758035A1 Liposome production using isopropanol |
| 07/30/2014 | EP2758034A1 Compositions and methods for molecular imaging of oxygen metabolism |
| 07/30/2014 | EP2758033A1 Method and composition for treating pain |